Department of Anatomy and Neurobiology, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536-0509, USA.
J Neurotrauma. 2012 Apr 10;29(6):1197-208. doi: 10.1089/neu.2011.2261.
Disrupted regulation of extracellular glutamate in the central nervous system contributes to and can exacerbate the acute pathophysiology of traumatic brain injury (TBI). Previously, we reported increased extracellular glutamate in the striatum of anesthetized rats 2 days after diffuse brain injury. To determine the mechanism(s) responsible for increased extracellular glutamate, we used enzyme-based microelectrode arrays (MEAs) coupled with specific pharmacological agents targeted at in vivo neuronal and glial regulation of extracellular glutamate. After TBI, extracellular glutamate was significantly increased in the striatum by (∼90%) averaging 4.1±0.6 μM compared with sham 2.2±0.4 μM. Calcium-dependent neuronal glutamate release, investigated by local application of an N-type calcium channel blocker, was no longer a significant source of extracellular glutamate after TBI, compared with sham. In brain-injured animals, inhibition of glutamate uptake with local application of an excitatory amino acid transporter inhibitor produced significantly greater increase in glutamate spillover (∼ 65%) from the synapses compared with sham. Furthermore, glutamate clearance measured by locally applying glutamate into the extracellular space revealed significant reductions in glutamate clearance parameters in brain-injured animals compared with sham. Taken together, these data indicate that disruptions in calcium-mediated glutamate release and glial regulation of extracellular glutamate contribute to increased extracellular glutamate in the striatum 2 days after diffuse brain injury. Overall, these data suggest that therapeutic strategies used to regulate glutamate release and uptake may improve excitatory circuit function and, possibly, outcomes following TBI.
中枢神经系统细胞外谷氨酸的调节紊乱导致并可能加重创伤性脑损伤 (TBI) 的急性病理生理学变化。此前,我们报道过弥漫性脑损伤后 2 天麻醉大鼠纹状体细胞外谷氨酸含量增加。为了确定导致细胞外谷氨酸增加的机制,我们使用基于酶的微电极阵列 (MEA) 结合针对体内神经元和神经胶质细胞调节细胞外谷氨酸的特定药理学试剂。TBI 后,纹状体细胞外谷氨酸显著增加(平均增加约 90%),达到 4.1±0.6 μM,而假手术组为 2.2±0.4 μM。与假手术组相比,TBI 后,局部应用 N 型钙通道阻滞剂后,钙依赖性神经元谷氨酸释放不再是细胞外谷氨酸的重要来源。在脑损伤动物中,局部应用兴奋性氨基酸转运体抑制剂抑制谷氨酸摄取会导致谷氨酸溢出(约 65%)显著增加,与假手术组相比。此外,通过将谷氨酸局部应用于细胞外空间测量谷氨酸清除率,发现在脑损伤动物中,谷氨酸清除率参数与假手术组相比显著降低。综上所述,这些数据表明钙介导的谷氨酸释放和神经胶质细胞对细胞外谷氨酸的调节紊乱导致弥漫性脑损伤后 2 天纹状体细胞外谷氨酸增加。总的来说,这些数据表明,用于调节谷氨酸释放和摄取的治疗策略可能改善兴奋性回路功能,并可能改善 TBI 后的结果。